Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

GUAFENSIN SYRUP 20MG/ML

Approval Number

SIN14283P

Drug Name

GUAFENSIN SYRUP 20MG/ML

Product Name

GUAFENSIN SYRUP 20MG/ML

Approval Date

December 31, 2012

Registrant

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

Registrant

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R05CA03

ATC Item Name

guaifenesin

Manufacturer Information

Pharmaceutical Manufacturer

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Manufacturers

Y.S.P. INDUSTRIES (M) SDN. BHD.

Active Ingredients

Ingredient Name

Guaifenesin

Strength

20mg/ml

Drug MonographGuaifenesin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

GUAFENSIN SYRUP 20MG/ML - HSA Approval | MedPath